Is Coherus Oncology, Inc. (CHRS) a Buy, Sell, or Hold?
NASDAQ : CHRS
Coherus Oncology, Inc. — Analyst Ratings
$1.48 USD
$0.04 (2.78%)
- Volume
- 616.17K
- Average Volume
- 1.03M
- Market Capitalization
- $181.17M
- P/E Ratio
- -1.16
- Dividend Yield
- 0.00%
- Price Target
- $6.00
- Year High
- $2.62
- Year Low
- $0.81
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.56
Analyst Consensus Summary
Consensus Rating
Strong Sell
16 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-75.3%
vs Current Price
Price Target
$6.00
Average TargetPrice Target Range
Lowest Target
$1.05
41.0% UPSIDE
Average Target
$6.00
Median Estimate
Highest Target
$11.00
-86.5% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 16
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 13 | 3 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| UBS | Ashwani Verma | $1.05 | $1.045 | 2025-04-24 09:04 AM | 0.5% |
| Robert W. Baird | Colleen Kusy | $6 | $1.735 | 2024-12-05 06:50 AM | 245.8% |
| UBS | Ashwani Verma | $7 | $6.19 | 2022-06-13 05:01 PM | 13.1% |